Antibiotic consumption and link to resistance

Clinical Microbiology and Infection

Volumn 15, Issue SUPPL. 3, 2009, Pages 12-15

  Goossens, Herman ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Antibiotic resistance; Antibiotic use; Antimicrobial pressure; Ecological study; S. pneumoniae

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GENE PRODUCT; LINCOSAMIDE; MACROLIDE; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DNA MODIFICATION; DRUG SURVEILLANCE PROGRAM; DRUG USE; EUROPE; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 65449170027     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02725.x     Document Type: Review

References (11)

1. Goossens H, Ferech M, Stichele RV, Elseviers M. ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet 2005; 365: 579-587.
2. Malhotra-Kumar S, Lammens C, Martel A et al. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: A prevalence study among healthy adults in Belgium. J Antimicrob Chemother 2004; 53: 271-276.
3. Goossens H, Ferech M, Coenen S, Stephens P. European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007; 44: 1091-1095.
4. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: A randomised, double-blind, placebo-controlled study. Lancet 2007; 369: 482-490.
5. European Surveillance of Antimicrobial Consumption (ESAC). Final scientific report. Antwerp, Belgium. February 2004-April 2007.
6. European Surveillance of Antimicrobial Consumption. Available at: http://www.esac.ua.ac.be/ (accessed 26 September 2008).
7. Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26: 1138-1180.
8. Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 2903-2913.
9. Jenkins SG, Farrell DJ, Patel M, Lavin BS. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect 2005; 51: 355-363.
10. Coenen S, Ferech M, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): Outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006; 58: 418-422.
11. Dias R, Canica M. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: Contribution and phylogenetic relatedness of serotype 14. J Antimicrob Chemother 2004; 54: 1035-1039.